---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-030866"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:46:11.404294+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BeOne Q1 2026: revenue $1.5B (+35%), BRUKINSA $1.1B (+38%), diluted EPS $1.96/$3.24

## Summary
- Total global revenue $1.5B for Q1 2026, up 35% from prior year.
- BRUKINSA global revenue $1.1B, up 38% YoY, maintains BTKi leadership.
- GAAP diluted EPS $1.96 (vs $0.01); non-GAAP diluted EPS $3.24 (vs $1.22).
- GAAP net income $227M (vs $1.3M); adjusted net income $375M (vs $136M).
- Free cash flow $161M, turnaround from negative $12M in prior year.

## SEC filing metadata
- accession: 0001628280-26-030866
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000162828026030866/0001628280-26-030866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000162828026030866/bgne-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-030866
- JSON: https://secwatch.observer/filing/0001628280-26-030866.json
- Plain text: https://secwatch.observer/filing/0001628280-26-030866.txt

## Source-grounded claims
- claim_id: 431abc8f8c93008e588fe3daaddc75d1e27408bd
  claim: BeOne Medicines Ltd. reported the three months ended March 31, 2026 results: revenue Total revenue $1,513,438, net income GAAP net income $227,357, EPS GAAP diluted EPS per ADS $1.96.
  evidence_excerpt: U.S. dollars and unaudited) Three Months Ended March 31, 2026 2025 % Change Net product revenues $ 1,487,329 $ 1,108,530 34 % Other revenue $ 26,109 $ 8,749 198 % Total revenue $ 1,513,438 $ 1,117,279 35 % GAAP income from operations $ 249,902 $ 11,102 2,151 % Adjusted income from operations* $ 414,394 $ 139,357 197 % GAAP net income $ 227,357 $ 1,270 17,802 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651308/000162828026030866/0001628280-26-030866-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.